Stocktwits on MSN
Armata Pharmaceuticals Stock Soars To Record High After Phage Therapy Data In Deadly Infection Trial; Retail Traders Pile In
The company’s bacteriophage therapy AP-SA02 achieved an 88% response rate in a Phase 2a trial for Staphylococcus aureus ...
Shares were mostly lower in Asia on Thursday following a retreat on Wall Street, while crude prices jumped more than $2 after ...
The U.S. stock market is drifting near its record heights on Tuesday as the floodgates open for companies reporting how much ...
Asian shares were mostly lower Wednesday on selling of technology shares following a lackluster day on Wall Street.
Microsoft says users of its Azure cloud portal may be not be able to access Office 365, Minecraft or other services due to ...
Nvidia is on track to become the first $5 trillion company, just three months after the Silicon Valley chipmaker was first to ...
Universal Music Group and AI platform Udio have settled a copyright lawsuit and will collaborate on a new music creation and ...
Hosted on MSN
Why Atai Life Sciences Stock Was So Lively This Week
The biotech earned an important fast-track review designation from a major regulator. This should speed the development (and potentially, commercialization) of one of its investigational treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback